Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2024 16:01 ET | Source: IN8bio, Inc

IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100

IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100
May 24, 2024 08:00 ET | Source: IN8bio, Inc

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
May 23, 2024 17:00 ET | Source: IN8bio, Inc

IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting

IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting